Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: 82626-01-5, Ananxyl, 2-(6-chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl)-n,n-dipropylacetamide, Sl 80.0342-00, 6-chloro-2-(p-chlorophenyl)-n,n-dipropylimidazo(1,2-a)pyridine-3-acetamide, 2-[6-chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]-n,n-dipropylacetamide
Molecular Formula
C21H23Cl2N3O
Molecular Weight
404.3  g/mol
InChI Key
JRTIDHTUMYMPRU-UHFFFAOYSA-N
FDA UNII
I93SC245QZ

1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[6-chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]-N,N-dipropylacetamide
2.1.2 InChI
InChI=1S/C21H23Cl2N3O/c1-3-11-25(12-4-2)20(27)13-18-21(15-5-7-16(22)8-6-15)24-19-10-9-17(23)14-26(18)19/h5-10,14H,3-4,11-13H2,1-2H3
2.1.3 InChI Key
JRTIDHTUMYMPRU-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCCN(CCC)C(=O)CC1=C(N=C2N1C=C(C=C2)Cl)C3=CC=C(C=C3)Cl
2.2 Other Identifiers
2.2.1 UNII
I93SC245QZ
2.3 Synonyms
2.3.1 MeSH Synonyms

1. S-800342

2. Sl 80-0342

2.3.2 Depositor-Supplied Synonyms

1. 82626-01-5

2. Ananxyl

3. 2-(6-chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl)-n,n-dipropylacetamide

4. Sl 80.0342-00

5. 6-chloro-2-(p-chlorophenyl)-n,n-dipropylimidazo(1,2-a)pyridine-3-acetamide

6. 2-[6-chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]-n,n-dipropylacetamide

7. Chembl54349

8. I93sc245qz

9. Sl-80.0342-00

10. 6-chlor-2-(4-chlorphenyl)-n,n-dipropylimidazol(1,2-a)pyridin-3-acetamid

11. Alpidemum [latin]

12. Ncgc00182850-01

13. Imidazo(1,2-a)pyridine-3-acetamide, 6-chloro-2-(4-chlorophenyl)-n,n-dipropyl-

14. Dsstox_cid_28972

15. Dsstox_rid_83237

16. Dsstox_gsid_49046

17. Alpidemum

18. Cas-82626-01-5

19. Alpidem [usan:inn:ban]

20. Unii-i93sc245qz

21. S-800342

22. Alpidem-[d14]

23. Alpidem (usan/inn)

24. Alpidem [usan]

25. Alpidem [inn]

26. Alpidem [mi]

27. Alpidem [mart.]

28. Alpidem [who-dd]

29. Schembl122619

30. Dtxsid8049046

31. Bdbm22041

32. Chebi:135649

33. Zinc599598

34. Tox21_113593

35. Alpidem, >=98% (hplc), Powder

36. Pdsp1_000633

37. Pdsp2_000628

38. Akos016014168

39. Tox21_113593_1

40. Cs-w013866

41. Hy-w013150

42. Ncgc00182850-02

43. Ft-0630911

44. D02833

45. A930152

46. Sr-01000944944

47. Q4735440

48. Sr-01000944944-1

49. 2-(6-chloro-2-(4-chlorophenyl)h-imidazo[1,2-a]pyridin-3-yl)-n,n-dipropylacetamide

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 404.3 g/mol
Molecular Formula C21H23Cl2N3O
XLogP34.8
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count2
Rotatable Bond Count7
Exact Mass403.1218178 g/mol
Monoisotopic Mass403.1218178 g/mol
Topological Polar Surface Area37.6 Ų
Heavy Atom Count27
Formal Charge0
Complexity478
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anti-Anxiety Agents

Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)